| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1076029613516190 |
| P8608 | Fatcat ID | release_z4hytgsr2jc33h4mclpmbnlyg4 |
| P698 | PubMed publication ID | 24363215 |
| P2093 | author name string | Ning Li | |
| Wenkui Yu | |||
| Kaipeng Duan | |||
| P2860 | cites work | Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin | Q24563384 |
| Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP | Q28188207 | ||
| Epidemiology of trauma deaths: a reassessment | Q28235326 | ||
| Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial | Q28285511 | ||
| Characterization of platelet dysfunction after trauma | Q33402029 | ||
| Antifibrinolytic therapy: new data and new concepts | Q33606553 | ||
| Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate | Q33919203 | ||
| Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury | Q33919248 | ||
| The endothelial surface layer. | Q34046782 | ||
| Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. | Q34135670 | ||
| Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage | Q34137787 | ||
| Remodeling the blood coagulation cascade | Q34294608 | ||
| Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS). | Q34334830 | ||
| Disseminated intravascular coagulation in trauma patients | Q34461301 | ||
| Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy | Q47441825 | ||
| Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. | Q50512736 | ||
| Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. | Q50574747 | ||
| Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. | Q50758503 | ||
| Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: comparison with acute coagulopathy of trauma-shock. | Q50984872 | ||
| Damage control resuscitation: directly addressing the early coagulopathy of trauma. | Q53578300 | ||
| Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma. | Q53677716 | ||
| The global burden of injuries | Q58024276 | ||
| Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock | Q35009637 | ||
| The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome | Q35051545 | ||
| Pathophysiology of early trauma-induced coagulopathy: emerging evidence for hemodilution and coagulation factor depletion | Q35091318 | ||
| Inflammation and thrombosis | Q35181574 | ||
| Functional definition and characterization of acute traumatic coagulopathy | Q35571219 | ||
| Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis | Q35760663 | ||
| Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. | Q36073044 | ||
| The endothelial glycocalyx: a potential barrier between health and vascular disease | Q36251700 | ||
| The interactions between inflammation and coagulation | Q36310877 | ||
| Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial | Q36465380 | ||
| Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients | Q36546261 | ||
| Increase in activated protein C mediates acute traumatic coagulopathy in mice | Q36615864 | ||
| Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. | Q36626556 | ||
| Damage control resuscitation | Q36843922 | ||
| Acute coagulopathy of trauma: mechanism, identification and effect | Q36987852 | ||
| The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital | Q37123037 | ||
| Evidence for indications of fresh frozen plasma | Q37145500 | ||
| The coagulopathy of trauma: a review of mechanisms | Q37292306 | ||
| Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. | Q37379818 | ||
| Macrophages and fibroblasts during inflammation, tissue damage and organ injury | Q37410537 | ||
| Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability | Q37546716 | ||
| Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality | Q37574545 | ||
| Inflammation and coagulation | Q37677466 | ||
| Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature | Q37849117 | ||
| Management of major trauma haemorrhage: treatment priorities and controversies | Q37948114 | ||
| Acute traumatic coagulopathy | Q37978188 | ||
| Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival | Q38063382 | ||
| Pathogenesis of acute traumatic coagulopathy | Q38072760 | ||
| The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial | Q39401875 | ||
| Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients | Q42012706 | ||
| Tranexamic acid: less bleeding and less thrombosis? | Q42106166 | ||
| Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia | Q42519962 | ||
| Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. | Q42937668 | ||
| The incidence and magnitude of fibrinolytic activation in trauma patients | Q44658013 | ||
| Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. | Q44869882 | ||
| Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. | Q45103688 | ||
| Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? | Q46166562 | ||
| Independent contributions of hypothermia and acidosis to coagulopathy in swine | Q46513794 | ||
| Early coagulopathy in trauma patients: an on-scene and hospital admission study. | Q46912713 | ||
| P433 | issue | 7 | |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | 645-652 | |
| P577 | publication date | 2013-12-19 | |
| P1433 | published in | Clinical and Applied Thrombosis-Hemostasis | Q5133805 |
| P1476 | title | The Pathophysiology and Management of Acute Traumatic Coagulopathy | |
| P478 | volume | 21 |
| Q45027732 | Assessment of hemostatic changes in a model of acute hemorrhage in dogs |
| Q35782678 | Induced Hypothermia Does Not Harm Hemodynamics after Polytrauma: A Porcine Model |
| Q26822626 | Research progress on combat trauma treatment in cold regions |
| Q52950888 | [Pathophysiology of hemorragic shock]. |
Search more.